1. Home
  2. VMD vs MBX Comparison

VMD vs MBX Comparison

Compare VMD & MBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VMD
  • MBX
  • Stock Information
  • Founded
  • VMD 2006
  • MBX 2018
  • Country
  • VMD United States
  • MBX United States
  • Employees
  • VMD N/A
  • MBX N/A
  • Industry
  • VMD
  • MBX
  • Sector
  • VMD
  • MBX
  • Exchange
  • VMD Nasdaq
  • MBX NYSE
  • Market Cap
  • VMD 279.4M
  • MBX 300.5M
  • IPO Year
  • VMD N/A
  • MBX 2024
  • Fundamental
  • Price
  • VMD $6.65
  • MBX $12.42
  • Analyst Decision
  • VMD
  • MBX Strong Buy
  • Analyst Count
  • VMD 0
  • MBX 5
  • Target Price
  • VMD N/A
  • MBX $37.40
  • AVG Volume (30 Days)
  • VMD 190.9K
  • MBX 255.6K
  • Earning Date
  • VMD 05-07-2025
  • MBX 05-12-2025
  • Dividend Yield
  • VMD N/A
  • MBX N/A
  • EPS Growth
  • VMD 19.95
  • MBX N/A
  • EPS
  • VMD 0.30
  • MBX N/A
  • Revenue
  • VMD $232,793,000.00
  • MBX N/A
  • Revenue This Year
  • VMD $17.35
  • MBX N/A
  • Revenue Next Year
  • VMD $12.87
  • MBX N/A
  • P/E Ratio
  • VMD $22.20
  • MBX N/A
  • Revenue Growth
  • VMD 19.97
  • MBX N/A
  • 52 Week Low
  • VMD $6.14
  • MBX $4.81
  • 52 Week High
  • VMD $9.81
  • MBX $27.50
  • Technical
  • Relative Strength Index (RSI)
  • VMD 46.10
  • MBX N/A
  • Support Level
  • VMD $6.36
  • MBX N/A
  • Resistance Level
  • VMD $6.84
  • MBX N/A
  • Average True Range (ATR)
  • VMD 0.21
  • MBX 0.00
  • MACD
  • VMD -0.01
  • MBX 0.00
  • Stochastic Oscillator
  • VMD 52.78
  • MBX 0.00

About VMD Viemed Healthcare Inc.

Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.

About MBX MBX BIOSCIENCES INC

MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.

Share on Social Networks: